Exchange: NASDAQ·Updated 07:32 PM EDT

ALMS News

News
all
press releases
This OGE Energy Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Analysts upgraded Alumis, Sirius XM, OGE Energy, revising their price targets and outlooks.read more...
Benzinga
More News
ALMS Stock Clocks Worst Day After 57% Drop — What Drove The Selloff?
The selloff followed topline results from the Phase 2b LUMUS trial of envudeucitinib in moderate-to-severe systemic lupus erythematosus, or SLE, a chronic autoimmune disease in which the body's immune system mistakenly attacks healthy tissues.
Stocktwits
Why Is Alumis Stock Falling Tuesday?
Alumis (ALMS) stock drops over 50% after Phase 2b lupus trial misses overall endpoints, but sub-group data shows promise.read more...
Benzinga
Alumis Psoriasis Treatment Shows Leading Skin Clearance Rates
Alumis releases long-term data for psoriasis drug envudeucitinib, boasting top skin clearance rates ahead of a Q4 FDA filing with FDA.read more...
Benzinga
4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026
PTGX, ALMS, ORKA and VNDA offer diverse psoriasis opportunities, spanning approved therapies, late-stage candidates and earlier-stage programs.
Zacks
Prothena (PRTA) Reports Q2 Loss, Misses Revenue Estimates
Prothena (PRTA) delivered earnings and revenue surprises of +17.95% and -1.94%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter
Key PointsDeep Track Capital bought 6,772,595 shares of Alumis last quarter; the estimated transaction value was $169.31 million (based on average prices...
Nasdaq News: Markets
Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter
Key PointsCormorant bought 313,645 additional Alumis shares in the first quarter; the estimated trade size was $7.84 million (using average prices in the quarter...
Nasdaq News: Markets
Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back
Key PointsOmega Fund Management sold 411,968 shares of Alumis; the estimated trade value is $10.3 million (based on quarterly average price...
Nasdaq News: Markets
This Alumis Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Top analysts changed outlook on top names. See all rating changes on analyst ratings page. Check out analysts' views on ALMS stock.read more...
Benzinga

Advertisement|Remove ads.